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Introduction
The primary defect in cystic fibrosis (CF) is a mutation
in CFTR gene found on the chromosome 7, on the long
arm at position q31.2. The advances in CF therapy
extended the mean length of life in these patients up to
36 years and improved their life quality. Early diagno-
sis is essential for proper therapy. Molecular examina-
tion in these patients does not necessarily confirm the
clinical diagnosis. Standard molecular examination
consists of maximum of 43 most frequent mutations of
CFTR gene, whereas at present over 1400 mutations
are known [7]. Due to large number of possible CFTR
mutations and diverse genotype-phenotype correla-
tion, it would be ideal to determine both mutations in
every patient [5]. 
Case history
Clinical characteristics 
22-year Caucasian male, birth mass 3490g, 9 pts. in
Apgar score, frequent pneumonia and bronchitis noted
from early infancy. CF was diagnosed at the age of 9
(1994) on the basis of clinical symptoms: chronic
cough with expectoration of thick sputum, numerous
alterations in auscultation, symptoms of chronic
hypoxygenation (clubbing) and positive sweat test.
Performed bronchography revealed numerous changes
in the bronchi (left lower lobe and lingua). Unequal
distribution of contrast medium and decreased number
of bronchi branches was also described. In lung func-
tion testing mild ventilation disturbances were
revealed. In sputum culture Stpahylococcus aureus
was observed. The patient was hospitalized twice due
to severe exacerbation of lung disease. Since 1998,
after Bordetella parapertussis infection, a significant
deterioration of spirometric values was noted, respec-
tively: FEV1 - 30% and FVC - 55% of predicted value
with concomitant Pseudomonas aeruginosa coloniza-
tion (Fig. 1). Number of severe exacerbations was sys-
tematically increasing with accompanying effort dysp-
noea.  In 2001 patient was hospitalized in Intensive
Care Unit due to left-sided spontaneous pneumotho-
rax.  The FEV1 and FVC were lowered until systemic
and inhaled steroids applied.
During follow-up, from December 2001 to May
2005, following radiographic changes were observed
(according to Brasfield score):
• lung distension, visible as depressed diaphrag-
matic leafs - 2nd stage
• linear markings in both lung fields - 2nd stage
• bronchi cuffing - 3rd stage
• large lesions visible as fibrosis - 3rd stage
Although, patient was classified as 2nd/3rd stage,
on the basis of general status and x-ray examination,
the incident of pneumothorax fulfill criteria for 5th
stage in Brasfield score.
Additional HRCT has revealed subpleural bullas,
bronchiectases, nodular cystic lesions, emphysema,
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adhesions limiting the pneumothorax and numerous,
enlarged mediastinal lymph nodes.  Advancement of
x-ray changes was also evaluated using Bhalla score
[2].
All performed imaging examinations correlated
well with patients' severe clinical status, however the
genotype was unknown.
At the age of seventeen, after incident of pneumoth-
orax, severe lung disease was diagnosed: nutritional sta-
tus indices were as follows Cole-Stanfield Index: 66%,
Schwachman Score: 40 pts, blood oxygenation parame-
ters O2 66.4%, pO2 34.9 mmHg, pCO2 45.2 mmHg.
Systemic steroid therapy, followed by inhaled steroids,
brought significant amelioration of nutritional status -
Cole-Stanfield Index: 83%, Schwachman Score 40 pts,
and blood oxygenation parameters: O2 95%, pO2 34.9
mmHg, pCO2 37.2 mmHg.
Molecular examination
Standard molecular examination revealed large dele-
tion del2,3, the mutation in second allele remained
unrecognized. Therefore whole gene sequencing was
performed. Analysis was performed in 5 ml of whole
blood. DNA was isolated from leukocytes using
QIAGEN kit and 27 exons of CFTR gene were ampli-
fied in PCR using primers from VariantSEQr™ Rese-
quencing Set (Applied Biosystems). Automatic
sequencing was performed on AB-Prism 3700
(Applied Biosystems). 
Results
In molecular testing a rare mutation, 2184insA (preva-
lence in Polish population <1% [8]), in exon 13 of
CFTR gene has been found (Fig. 2). Furthermore two
common sequence variants were found: 1540G/A and
4521G/A respectively in exons 10 and 24.
Discussion
From over 1400 known mutations of CFTR gene all
types of nucleotides sequence changes are observed:
non-sense mutations, frameshift, splicing, small and
large deletions, insertions.  Large deletions make
around 3% of all mutations in CFTR gene.  The preva-
lence of del2,3 in polish population is 2% [1]. This
mutation belongs to severe class of CFTR mutation - the
defect in which deletion of 21kb including exons 2 and
3 is related with severe CF course (high concentration of
chloride ions in sweat, pancreatic insufficiency, early
Pseudomonas aeruginosa colonization) [3]. 
2184insA mutations, which insertion of adenine in
position 2184 causes frameshift, was described for the
first time in two German patients [4]. Described clini-
cal case correspond with severe CF course.  Preva-
lence of this mutation is relatively high in Eastern
Europe and in Russia (>7%) [6]. 
At this time there was no published case of
del2,3/2184insA genotype. According to literature,
presence of one of the mutations, del2,3 or 2184insA,
is responsible for severe cystic fibrosis course (high
concentration of chloride ions in sweat, pancreatic
insufficiency, early Pseudomonas aeruginosa colo-
48 A. Minarowska et al. 
Fig. 1 FEV1 and FVC changes in presented
patient expressed as percentage of on pre-
dicted values 
Fig. 2 2184insA mutation in presented patient
nization) from early age. Delayed age of diagnosis and
mild clinical symptoms does not confirm these obser-
vations. At the moment, natural history of presented
patient is typical for genotype-phenotype correlation
for identified mutations, but proper and complex ther-
apy decreased the progress of lung disease. Therefore
early molecular diagnosis of mutations in CFTR gene
would allow to apply intensive therapy, what should
hold back the Pseudomonas aeruginosa chronic colo-
nization in respiratory tract and severe complications
of lung disease. Noteworthy is a fact of good response
for applied systemic and inhaled steroid therapy.
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